Skip to main content

Table 2 The fatty acid content and ratios in the mice liver

From: Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease

Fatty acid

Control group

Experimental group

C14:0 (μg/mg)

0.47 ± 0.13

2.39 ± 0.66**

C15:0 (μg/mg)

0.34 ± 0.12

0.18 ± 0.04**

C16:0 (μg/mg)

23.41 ± 7.72

70.08 ± 17.95**

C17:0 (μg/mg)

0.35 ± 0.11

0.41 ± 0.10

C18:0 (μg/mg)

11.07 ± 4.07

17.33 ± 5.15**

C18:1 n-9 (μg/mg)

93.87 ± 19.62

56.69 ± 19.08**

C18:2 n-6 (μg/mg)

84.96 ± 27.43

42.12 ± 22.11**

C18:3 n-3 (μg/mg)

2.76 ± 1.43

1.07 ± 0.66**

C20:1 n-9 (μg/mg)

0.94 ± 0.34

0.97 ± 0.38

C20:3 n-6 (μg/mg)

1.19 ± 0.44

2.10 ± 0.78**

C20:4 n-6 (μg/mg)

14.89 ± 5.18

11.10 ± 4.37

C20:5 n-3 (μg/mg)

0.64 ± 0.21

1.06 ± 0.57

C22:6 n-3 (μg/mg)

7.36 ± 4.76

6.57 ± 3.95

TFA (μg/mg)

242.24 ± 14.44

212.79 ± 11.95**

SFA (μg/mg)

35.64 ± 6.15

91.11 ± 6.92**

UFA (μg/mg)

206.60 ± 14.62

121.68 ± 12.07**

MUFA (μg/mg)

94.81 ± 10.53

57.66 ± 11.46**

PUFA (μg/mg)

111.80 ± 10.51

64.02 ± 8.38**

SFA/TFA ratio (%)

14.73 ± 2.44

42.89 ± 3.26**

UFA/TFA ratio (%)

85.27 ± 2.44

57.11 ± 3.43**

PUFA/SFA ratio (%)

323.23 ± 66.64

70.03 ± 11.05**

MUFA/SFA ratio (%)

273.63 ± 59.59

63.91 ± 14.62**

n-6/n-6 ratio (%)

18.04 ± 5.04

28.15 ± 8.90**

n-3/n-3 ratio (%)

286.69 ± 67.02

740.80 ± 58.75**

n-6/n-3 ratio (%)

188.29 ± 15.51

143.33 ± 13.66**

  1. All of the values are expressed as mean ± standard deviation (SD) (n = 20 per treatment group). TFA, total fatty acid; SFA, saturated fatty acid; UFA, unsaturated fatty acid; PUFA, polyunsaturated fatty acid; MUFA, monounsaturated fatty acid; n-6/n-6 ratio, C20:4/C18:2; n-3/n-3 ratio, (C20:5+ C22:6)/C18:3; n-6/n-3 ratio, C20:4/(C20:5+C22:6). **P < 0.01 vs. the control group.